Evento
Circulating cytokine levels in Chagas patients with and without dilated cardiomyopathy
Miranda, Silvia Esther
; Sosa, Gustavo; Lombardi, María Gabriela
; Von Wulffen, Alejandra; Campi, Natalia; Paolucci, Analia; Principato, Mario Bruno; Carbajales, Justo; Di Girolamo, Guillermo
Tipo del evento:
Reunión
Nombre del evento:
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento:
13/11/2019
Institución Organizadora:
Sociedad Argentina de Investigación Clínica;
Asociación Argentina de Farmacología Experimental;
Sociedad Argentina de Biología;
Sociedad Argentina de Protozoología;
Asociación Argentina de Nanomedicinas;
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio;
Título de la revista:
Medicina (Buenos Aires)
Editorial:
Fundación Revista Medicina
Idioma:
Inglés
Clasificación temática:
Resumen
Dilated cardiomyopathy (DC) represents the most severe manifestation that affects ≈30% of individuals along 10-30 years after T. cruzi infection. To study the underlying mechanisms, circulating levels of different cytokines/chemokines were investigated in patients with DC or not (NC) and compared with healthy control donors (C).Chagas´ patients were recruited by the Cardiogenetic Center, Ramos Mejía Hospital, Bs. As., after signing the informed consent approved by the local Ethics Committee. All patients came from northwestern Argentina and southern Bolivia. No patient presented another etiology of dilated cardiomyopathy except Chagas. Enrolled patients were submitted to a standard follow up and clinical treatment. The NC group (n=22) included asymptomatic individuals, with ejection fraction (EF) more than 50 % and DC group (n=22) showed EF less than 35%. Normal healthy volunteers showing negative serological tests for the infection were included as the (C) group (n=14). Fasting plasma levels of IFNγ, IL-1β, IL-6, IL-10, IL-12 (p70), IL-15, IL-17A, MCP-1/CCL2, MIP-1alpha/CCL3, TNFalpha and IL-2 were assessed using a Magnetic Bead Multiplex Assay in a Magpix® equipment (Merck Millipore). Concentrations were determined using the xPONENT software version 4.2.Our results showed that: 1- DC, in contrast to NC, had higher levels of TNFalpha than C (p: 0.010), 2- IL-6 concentration increased in DC with respect to NC (p: 0.033), 3- NC showed a trend to higher MCP-1 levels respect to DC (p: 0.119), 4-no differences were observed in the rest of the analyzed cytokines. These data suggest that IL-17A producing cells (IL3 and Th17) and INF-γ producers (NK, Tc, Th1 cells) have a little contribution in this phase of the disease. The present observations agree with the similar levels of IL-2, IL-12p70 and IL-15 found in all groups. In contrast, IL-6 and TNFalpha, likely derived from monocytes/macrophages, would contribute to cardiac inflammation and dysfunction in Chagas disease.
Palabras clave:
Chagas
,
cytokine
,
Dilated cardiomyopathy
,
T. cruzi infection
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos (IATIMET)
Eventos de INSTITUTO ALBERTO C. TAQUINI DE INVESTIGACIONES EN MEDICINA TRASLACIONAL
Eventos de INSTITUTO ALBERTO C. TAQUINI DE INVESTIGACIONES EN MEDICINA TRASLACIONAL
Eventos(SEDE CENTRAL)
Eventos de SEDE CENTRAL
Eventos de SEDE CENTRAL
Citación
Circulating cytokine levels in Chagas patients with and without dilated cardiomyopathy; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2019; 1-1
Compartir